Lead Story
Use of new EMA platform for monitoring medicine shortages to become mandatory
The European Medicines Agency (EMA) has launched the European Shortages Monitoring Platform (ESMP), aimed at preventing and managing shortages of centrally authorised products (CAPs).
Industry news
Increased debate over lecanemab
The Lancet has published an editorial encouraging regulators and clinicians to ‘keep an open mind’ about lecanemab, the first drug aimed at slowing the progression of Alzheimer’s disease.
GSK Blenrep trial shows ‘significant overall survival benefit’of myeloma treatment
According to a report by GSK, a recent clinical trial has revealed that Blenrep can reduce the risk of death by 42% in multiple myeloma after relapse.
Greater post-market surveillance for medical devices
New draft legislation was laid before the UK Parliament on 21 October 2024 which would require greater post-market surveillance (PMS) for medical devices on the market in Great Britain.
FDA proposes to remove oral phenylephrine in selected drugs
The US Food and Drug Administration (FDA) has released an update proposing the removal of oral phenylephrine as the active ingredient in drugs for treating nasal congestion.
More news
WHO Pandemic Agreement gains signatories
Regulators publish new guidelines for use of AI
New Editor-in-Chief for Regulatory Rapporteur
WHO issues warning on fake opioids in Europe
Contraindication for mixing weight loss medicine Mysimba with opioids
UK pledges to join the Trans-Pacific Partnership by end of 2024
NICE and EMA say new Alzheimer’s drug is ‘not recommended’
